A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/121 (2006.01) A61K 31/352 (2006.01) A61K 31/353 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2651795
The present invention relates to the treatment of therapy-resistant neoplasias. The compounds and methods of the invention are particularly useful for the treatment of taxol-resistant human cancers, particularly cervical and breast cancer. Components of the compositions of the present invention show strong synergy with one another allowing them to be used in relatively low amounts for the treatment of stage IV or recurrent cancer which may have grown resistant to the traditional chemotherapeutic agents. These compositions comprise oridonin.
La présente invention concerne le traitement de néoplasies réfractaires à la thérapie. Les composés ainsi que les méthodes de cette invention sont particulièrement utiles pour le traitement des cancers humains résistants au Taxol, en particulier les cancers du sein et du cerveau. Les composés de cette composition ont une très forte synergie les uns par rapport aux autres ce qui permet de les utiliser à des doses relativement faibles lors du traitement de cancers de stade IV ou de cancers récurrents qui peuvent avoir une résistance plus forte aux agents chimiothérapeutiques traditionnels. Ces compositions contiennent de l'oridonine.
Activephyto Technologies Limited
Cassan Maclean
LandOfFree
Composition for the treatment of resistant cancers... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for the treatment of resistant cancers..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for the treatment of resistant cancers... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2050752